Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Endoscopic Add-on System for Ulcerative Colitis Patients (ENACT) | 2023 - 2024 | Innoexplorer
|
|
|
Endoscopic Add-on System for Ulcerative Colitis Patients (ENACT)
Period
2023 - 2024
Region
Program
Innoexplorer Area
Ikke defineret Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
HVIDOVRE HOSPITAL People
Read more about the project
| |||
| Endotyping of spondyloarthritis patients: Understanding extracellular matrix remodeling in axial spondyloarthritis and the association with disease activity and severity | 2020 - 2023 | Industrial Researcher
|
|
|
Endotyping of spondyloarthritis patients: Understanding extracellular matrix remodeling in axial spondyloarthritis and the association with disease activity and severity
Period
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.1 mill. Budget
1.1 mill. Partners
University of Copenhagen, NORDIC BIOSCIENCE A/S People
NORDIC BIOSCIENCE A/S
Read more about the project
| |||
| Energi effektiv brand- og sikringsdør | 2018 - 2018 | Innobooster
|
|
|
Energi effektiv brand- og sikringsdør
Period
2018 - 2018
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
15.28 Invested
107.325 Budget
702.500 Partners
MX Door Aps People
MX Door ApS
Read more about the project
| |||
| Energi- og kosteffektiv rensning for lægemidler via aquaporiner | 2018 - 2018 | Innobooster
|
|
|
Energi- og kosteffektiv rensning for lægemidler via aquaporiner
Period
2018 - 2018
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
30.6 Invested
440.638 Budget
1.4 mill. Partners
Aquaporin A/S People
AQUAPORIN A/S
Read more about the project
| |||
| Energiantropologi | 2015 - 2016 | Innobooster
|
|
|
Energiantropologi
Period
2015 - 2016
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
27.59 Invested
491.857 Budget
1.8 mill. Partners
TRANSITION ApS People
TRANSITION ApS
Read more about the project
| |||
| Energieffektiv forbehandling af biomasse | 2016 - 2017 | Innobooster
|
|
|
Energieffektiv forbehandling af biomasse
Period
2016 - 2017
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
31.55 Invested
152.381 Budget
483.000 Partners
Kriska BioTech ApS People
Kriska BioTech ApS
Read more about the project
| |||
| Energieffektiv Motor | 2020 - 2022 | Innobooster
|
|
|
Energieffektiv Motor
Period
2020 - 2022
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
1.1 mill. Budget
3.3 mill. Partners
DACS A/S People
DACS A/S
Read more about the project
| |||
| Energioptimering af ventilationskanaler | 2024 - 2025 | Innobooster
|
|
|
Energioptimering af ventilationskanaler
Period
2024 - 2025
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
795.812 Budget
2.3 mill. Partners
Coatable A/S People
Read more about the project
| |||
| Energioptimering og balanceringsydelser | 2024 - 2024 | Innobooster
|
|
|
Energioptimering og balanceringsydelser
Period
2024 - 2024
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
310.625 Budget
887.500 Partners
Copenhagen Atomics A/S People
Read more about the project
| |||
| Energioptimering på skibe | 2021 - 2022 | Innobooster
|
|
|
Energioptimering på skibe
Period
2021 - 2022
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
32.99 Invested
287.000 Budget
870.000 Partners
NowiTek ApS People
NowiTek ApS
Read more about the project
| |||
| Energy Harvesting sensors | 2016 - 2016 | Innobooster
|
|
|
Energy Harvesting sensors
Period
2016 - 2016
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
19.94 Invested
264.083 Budget
1.3 mill. Partners
XTEL ApS People
XTEL ApS
Read more about the project
| |||
| Energy Saving til radiokædesystemer | 2019 - 2020 | Innobooster
|
|
|
Energy Saving til radiokædesystemer
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
32.31 Invested
456.000 Budget
1.4 mill. Partners
INUATEK IVS People
Inuatek A/S
Read more about the project
| |||
| Energy-efficient and Cost-effective Reconfigurable Intelligent Surface with Multiple Panels for 6th Generation Millimeter-wave Wireless Communications (EcoSurf6G) | 2024 - 2025 | Innoexplorer
|
|
|
Energy-efficient and Cost-effective Reconfigurable Intelligent Surface with Multiple Panels for 6th Generation Millimeter-wave Wireless Communications (EcoSurf6G)
Period
2024 - 2025
Region
Program
Innoexplorer Area
Ikke defineret Investment
Percentage
100 Invested
1.4 mill. Budget
1.4 mill. Partners
Aalborg Universitet, FRB7B People
Read more about the project
| |||
| EnergyMill | 2018 - 2018 | Innobooster
|
|
|
EnergyMill
Period
2018 - 2018
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
31.82 Invested
314.768 Budget
989.250 Partners
Energy-Mill ApS People
Energy-mill Aps
Read more about the project
| |||
| EngageRx - Pharma’s Live Insight Engine | 2026 - 2027 | Innofounder
|
|
|
EngageRx - Pharma’s Live Insight Engine
Period
2026 - 2027
Region
Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
760.000 Budget
760.000 EngageRx: Pharmas mest kraftfulde indsigtsmotor
Ved at omdanne daglige samtaler mellem salgsrepræsentanter og sundhedspersonale til compliant, realtidsbaserede og skalerbare markedsindsigter skaber EngageRx pharmas mest kraftfulde indsigtsmotor.
I dag bruger pharma milliarder på at forstå, hvad sundhedspersonale har brug for, men traditionelle metoder er langsomme, dyre, uskalerbare og utroværdige - og ofte forældede, når informationen er indsamlet. Samtidig findes den rigeste kilde til indsigt i de hundredtusindvis af daglige samtaler, som pharma har med sundhedspersonale verden over.
Vores løsning indfanger de 99 % af datapunkter, der i dag går tabt. Med eksplicit samtykke fra sundhedspersonalet bliver hvert møde et compliant og formålsbegrænset datapunkt i et nyt datalag af kundeindsigter. Disse akkumuleres i en aggregeret visning, så pharma-teams kan identificere trends og mønstre - for at skalere det, der virker, og adressere det, der ikke virker. Resultatet er bedre interaktion med sundhedspersonale og ultimativt bedre patientbehandling.
Innovationsfondens investering hjælper os fra prototype til første enterprise-pilot med en førende pharmavirksomhed ved at overkomme kritiske barrierer inden for compliance, IT-sikkerhed og CRM-integration.
På den lange bane sigter EngageRx mod at blive de factor-indsigtslaget for global pharma.
Partners
EngageRx ApS People
EngageRx ApS
Read more about the project
| |||